Crabel Capital Management, LLC Amgen Inc Transaction History

Crabel Capital Management, LLC

  • $81.4 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020
SELL
$182.24 - $241.7 $468,539 - $621,410
-2,571 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$189.21 - $243.2 $44,653 - $57,395
236 Added 10.11%
2,571 $620,000
Q3 2019

Nov 13, 2019
BUY
$174.11 - $208.62 $406,546 - $487,127
2,335 New
2,335 $452,000

Others Institutions Holding AMGN

# of Institutions
3,055
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Crabel Capital Management, LLC Portfolio

Follow Crabel Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crabel Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crabel Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email